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Summary 
Most carcinomas present some form of genetic instability, either as a shortening or lengthening of PCR markers termed 
microsatellite instability or as a change in the relative intensity of paternal and maternal alleles trmed chromosomal 
instability. Although chromosomal instability is found in the vast majority of carcinomas, its exact contribution to tumor 
formation has long been a matter of debate. The mutagenic effects associated with microsatellite instabili y might active 
known oncogenes, and therefore are an accepted cause of cellular transformation, but the mere numerical changes 
associated with chromosomal instability only seem to compromise cellular fitness. Whereas the mitotic rigins of 
aneuploidy are now accepted, the role of spindle microtubules in chromosome breakage and translocations remains 
disputed. Nonetheless, a comparison of several proposed mechanisms of structural instability reveals a triking 
convergence towards a key role for merotelic kinetochore attachments, which is further corroborated by the pattern of 
copy number alterations in clinical tumors. The recent discovery of gene dosage effects and cancer stem cells hint at the 
deregulation of intertwined regulatory networks and a cellular response to reduced fitness as a possible carcinogenic 
mechanism related to chromosomal instability. These em rging paradigms of cancer however need to be validated by 
relevant experimental models. 
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Introduction 
Most tumors show complex patterns of translocations, 
amplifications, and deletions, which have kept scientist 
occupied for decades. A specific problem occurs in 
carcinomas, most of which suffer from a particular kind 
of genetic defect termed chromosomal instability 
(CIN); these solid tumors combine gains and losses of 
entire chromosomes with segmental defects caused by 
chromosome breaks.  
Another, indpendent class of tumors shows a different 
type of genetic alterations termed miscrosatellite 
instability (MIN). The terms MIN and CIN were 
originally devised to describe how a particular pattern 
of PCR markers - typically di- and trinucleotide repeats 
- deviates from the control, and in this way give an 
indication of the phenotype carried by the 
corresponding tumor sample or cell line. MIN is 
manifested by a shortening or lengthening of PCR 
markers compared to the same marker in the control 
tissue. MIN is a condition contributed to defects in 
DNA mismatch repair on the basepair level (Røyrvik et 
al., 2007). Whereas MIN results in a size difference, 
CIN manifests itself as a change in the relative int nsity 
of PCR markers compared to the same marker in the 
control tissue. Only certain markers, for which the 
paternal and maternal alleles have a natural size 
difference, can be evaluated for intensity changes, and  
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are termed informative. Differences in the intensity of 
two alleles signal a copy number of the corresponding 
genomic region, brought about by the loss or gain of a
large chromosome fragment or entire chromosome in 
the corresponding cancer (Geigl et al., 2008). The 
frequent observation of aneuploidy in the 
corresponding tumors suggests that chromosome 
segregation defects are a possible mechanism leading 
to CIN. 
Available data indicate that CIN is the most common 
instability phenotype. The relatively small proporti n 
of tumors that show MIN, approximately 15% of 
detected cases, are distinctly associated with a 
hereditary component (Charames and Bapat, 2003; 
Pihan and Doxsey, 2003); the defects in DNA 
mismatch repair are usually caused by recessive 
mutations and only become evident in homozygosis 
(Røyrvik et al., 2007). In addition to several hereditary 
conditions that cause CIN, this type of instability has 
been found in approximately 85% of sporadic 
carcinomas. Whereas the carcinogenic potential of 
MIN has been recognized early on - defects in 
mismatch repair might directly lead to mutations in 
oncogenes and tumor suppressor genes -, the relation 
between CIN and cancer has remained unclear for a 
long time. A search for mutations that cause CIN has
identified more than a hunderd candidate genes in yeast 
(Spencer et al., 1990), underlining the complexity of 
this type of genetic instability. The question as how 
mere numerical alterations can provoke cellular 
transformation still is a matter of debate. One suggested 
mechanism involves the collaboration of MIN and CIN 
in a tumor progression (Pihan and Doxsey, 2003). 
According to this theory, CIN can amplify the 
carcinogenic effects of MIN by generating additional 
copies of activated oncogenes. Although evidence for 
widespread MIN and CIN in a single sample is 
occasionally found (Abdel-Rahman et al., 2001), most 
CIN tumors seem to accumulate mutations only in a 
limited number of oncogenes and suppressor genes and 
do not show systematic MIN. Other studies indicate 
that numerical alterations arise before sequence 
alterations (Nowak et al., 2002), and that CIN has an 
oncogenic effect independent of intragenic mutations 
(Abdel-Rahman et al., 2005). Thus, mutations in tumor 
suppressor genes might evolve through a compensatory 
mechanism that is selected for by CIN, instead of 
comprising a primary cause of carcinogenesis. These 
data indicate a role of CIN that is far more important 
and complex than the induction of copy number 
alterations in oncogenes alone. 
In this review, I will discuss some of the current  
models describing the early steps in sporadic 
carcinogenesis, with a special focus on the formation of 
chromosomal instability (CIN). CIN comprises 
alterations in whole chromosomes (W-CIN), described 
in detail in a large number of publications and therefore 
reviewed only briefly here, and structural alterations 
(S-CIN) still subject to speculation and thus evaluated 
in more detail. Furthermore, the most important 
downstream effects of CIN will be discussed; W-CIN 
and S-CIN invariably result in copy number alterations, 
and therefore in an imbalanced expression pattern for a
large number of genes.  
This expression imbalance produces a gene dosage 
effect in cells affected by CIN, in the form of an 
unfolded protein response (Herr and Debatin, 2001). A 
prolonged unfolded protein response might be an 
important selection mechanism, promoting resistance to 
apoptosis and cell transformation in CIN tumors. The 
relation between gene dosage and cell transformation 
will be the subject of the final paragraphs of this 
review. 
CIN comprises aneuploidy and 
breakage 
The chromosomal instability observed in 
approximately 85% of all solid tumors can be divided 
in two major components: gains and losses of entire 
chromosomes termed aneuploidy or whole 
chromosome instability (W-CIN), and segmental 
defects (S-CIN) that comprises formation of breaks nd
fusion of chromosome sections (Geigl et al., 2008).  
These two phenomena regularly occur together in a 
single tumor sample or cell line, and quantitation has 
shown that the levels of W-CIN and S-CIN are 
proportional (Duesberg et al., 1998; Fabarius et al., 
2003). In tumors that show MIN, neither W-CIN nor S-
CIN is normally found (Abdel-Rahman et al., 2001). 
Notwithstanding the correlation between the two 
phenomena, W-CIN is understood in far more detail 
than S-CIN; most carcinomas show variations in 
chromosome number that arise from the losses and 
gains of entire chromosomes during mitosis. 
The cell division is one of the most dramatic events i  
the cell cycle, and other processes such as RNA 
transcription are largely suppressed during mitosis 
(Egli et al., 2008) so the cell can dedicate its resources 
to chromosome segregation. Since the cell temporarily 
suspends some vital processes, the total duration of 
mitosis is limited. To ensure rapid but correct 
chromosome segregation in mitosis, metazoans have 
evolved an elaborate regulatory network controlling 
chromosome capture by the mitotic spindle.  
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Figure 1. Comparison of yeast and mammalian chromosome segregation. The small chromosomes in lower organisms (left) require 
just one microtubule or fiber (red) for efficient separation in anaphase, but the large chromosomes in higher organisms (middle) are 
segregated only by the combined force of multiple K-fibers. The amplification of the number of fibers needed for chromosome 
segregation leads to occasional merotelic attachments (blue, right) detected poorly by the SAC, but potentially leading to W-CIN and S-
CIN. 
 
In yeast, a search for mutations that cause CIN has 
identified more than a hunderd candidate genes 
(Spencer et al., 1990), many of which have multiple 
orthologs in humans. The complexity of the network 
that controls chromosome segregation however reflects 
the magnitude of the problem faced, and spontaneous 
chromosome segregation errors occur at a measurable 
rate even in the tightly controlled mitotic spindle, 
leading to W-CIN (King, 2008; Compton, 2011). The 
problem lies in the need to control simultaneous 
segregation of all chromosomes - the transition form 
metaphase to anaphase - at the cellular level but capture 
of each chromosome at the level of the individual 
kinetochore. Tension is used to test attachment of each 
kinetochore individually, and a single unbound 
kinetochore is enough to delay anaphase (Rieder et al., 
1994). Whereas segregation of the relatively small 
chromosomes of yeast can be accomplished with a 
single microtubule, the large mammalian chromosomes 
require large bundles of microtubules, termed K-fibers, 
for rapid segregation. When multiple fibers are used to 
segregate a single chromatid, tension no longer is a
faithful measure for kinetochore attachment (Figure 1). 
Total lack of kinetochore capture still results in absence 
of tension, but capture of a single kinetochore by 
microtubules protruding form different spindle poles - 
termed merotelic attachment - might provide enough 
tension to signal anaphase progression but could lead to 
incorrect chromosome segregation (Cimini and 
Degrassi, 2005). The need for multiple microtubules 
for the segregation of each sister chromatid thus ha  
lead to a biological problem that as of yet still has not 
been resolved. Over the last decade, merotelic 
kinetochore attachment has been accepted as a major
cause of W-CIN in human cancer. 
In contrast to W-CIN, for which the role of the mitot c 
spindle has been consolidated in the last years, possible 
mechanisms of S-CIN still are part of a dynamic field 
of discovery. Over the last years, several hypotheses 
have considered a link between CIN and cellular 
processes ranging from DNA replication (Crasta et al., 
2012) to telomere erosion (Stewart and Bertuch, 2010) 
and cytokinesis (Janssen et al., 2011). Thus, W-CIN is 
the result from a reasonably homogeneous group of 
experiments involving chromosome segregation, but S-
CIN might be caused by a range of experimental 
conditions. Notwithstanding the variety of theories, the 
simplest explanation entails a common origin for W-
CIN and S-CIN (Martínez-A and van Wely, 2010). 
Experimentally induced S-CIN and 
the role of mitosis 
Whereas aneuploidy has been tied to defects in mitotic 
chromosome segregation early on, the origins of S-CIN 
have remained unknown for a long time. Even today, it 
remains a matter of debate if W-CIN and S-CIN are 
caused by a single defect or have different origins 
(Martínez-A and van Wely, 2010). The different 
models agree that chromosome breakage is a crucial 
step in the generation of S-CIN, as translocations are 
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the result of a chromosome fragment fused to a 
genomic location other than the one it originated from. 
The origins of DSB in CIN cells however are explained 
in a number of different ways. Below, I will discuss 
some models that explain the formation of chromosome 
breaks under conditions that induce W-CIN. 
Since W-CIN and S-CIN are frequently observed in 
single samples, a logical point to start a search for DSB 
is the mitotic spindle. Chromosomes are attached to 
spindle microtubules through the kinetochore-
centromere interface, and the metaphase to anaphase 
transition marks the moment in which pulling forced 
physically segregate the sister chromatids. In merotelic 
attachments, kinetochores are bound to microtubules 
that project from both spindle poles and experience part 
of the tension that signals for degradation of cohesion 
molecules (Figure 1). Since merotelic attachments 
inefficiently activate the SAC, some cells progress into 
anaphase even though chromosomes are coupled to 
both spindle poles (Cimini et al., 2003), exposing the
kinetochore to additional tension that leads to a 
physical deformation (Cimini et al., 2001). This 
situation is a consequence of the larger chromosome in 
mammals and the need for many parallel microtubules 
to segregate chromosomes. Adding microtubules to 
segregate the sister chromatids is an evolutionary 
compromise to prevent excessive duration of anaphase, 
and the result is that the combined strength of 
microtubules capturing a typical mammalian 
kinetochore exceeds the pulling force needed to break 
the DNA backbone (Guerrero et al., 2010b). 
Mutants with a reduced control of the SAC show a 
combination of W-CIN and S-CIN (Trachana et al., 
2007; Guerrero et al., 2010b). In these mutants, the 
deformation of kinetochores in merotelic attachments is 
noticeable in the connected centromere chromatin, 
which also undergoes physical stretching. If the 
merotelic attachment persists and the microtubules 
exert enough force, breakage of centromere DNA 
follows (Guerrero et al., 2010b). In agreement with a 
model for merotelic attachments that places 
microtubules projected to the opposite pole at the 
periphery of the kinetochore (Cimini et al., 2001), 
many breakpoints localize to the edges of the 
centromere (Martínez et al., 2012). A chromosome 
damaged in mitosis can thus be divided in an arm 
bearing a functional centromere and an arm lacking 
centromere activity (Martínez-A and van Wely, 2010), 
explaining why different DSB repair pathways generat  
neoacrocentric chromosomes (Gagos et al., 2008) and 
tandem fusion to the telomeres of healthy acceptor 
chromosomes (Martínez and van Wely, 2011). The 
contribution of DSB repair in S-CIN will be discussed 
further below. 
Whereas the initial description of mitotic DNA damage 
identified DSB formation in freely cycling cells, later 
studies have applied spindle poisons to increase the 
number of cells in mitosis (Janssen et al., 2011; Crasta 
et al., 2012). A release from the metaphase block 
allows for the identification of DNA damage in 
subsequent cell cycle phases, but ignores a possible 
contribution of the early stages of cell division. 
Surprisingly, although two studies used compounds 
that alter microtubule behavior, either monastrol or 
nocodazole (Janssen et al., 2011; Crasta et al., 2012), 
very different results were obtained. The first use of 
spindle poisons sprouted the hypothesis that cytokinesis 
accounts for cleavage of trapped chromosomes and 
thereby causes S-CIN (Janssen et al., 2011). After 
monastrol release, damaged chromosomes were indeed 
found close to the cleavage furrow, in contrast to 
damage signals in spindle control mutants, which 
localize to micronuclei and occasionally inside the 
main nucleus (Guerrero et al., 2010a). Colocalization of 
damaged chromosomes and cleavage furrow however 
is a logical consequence of merotelic attachments, since 
the position of the actin ring in cytokinesis is 
determined largely by spindle midzone microtubules 
that transverse the previous metaphase plate (Wheatley 
and Wang, 1996). In conclusion, damaged 
chromosomes probably are trapped close to cleavage 
furrow probably by a prior event, and are no direct 
consequence of actin ring constriction.  
The second argument to implicate cytokinesis in 
chromosome breakage was the time of DSB formation. 
Strikingly, DNA damage was first observed within 
minutes of release from the mitotic block, based on the 
appearance of the DSB marker 53BP1 (Janssen et al., 
2011), even though cytokinesis is not started until half 
an hour later. This time difference excludes cytokines s 
from the possible causes of breaks directly after drug 
release. Kinetic studies have shown that 53BP1 
accumulation is a relatively slow process; 53BP1 takes 
5-15 minutes to appear on induced DSB (Schultz et al., 
2000).  
This timeframe might be even longer in cell division, 
because 53BP1 is excluded from DSB during most of 
mitosis (Giunta and Jackson, 2011). The combined data 
indicate that DSB likely appear within minutes of drug 
release, and that resolution of merotelic attachments in 
the monopolar spindle are the most probable cause of 
DNA damage. 
A final model has suggested errors in DNA replication 
as a source of S-CIN (Crasta et al., 2012). For ovea 
decade, DNA replication errors have been associated 
with concrete chromosomal loci termed fragile sites, in 
which DSB can be induced experimentally by 
treatment with DNA polymerase inhibitors (Arlt et al., 
2003).  
Fragile sites are thought to represent loci that requi  
more time to replicate than the remainder of chromatin, 
because a particular basepair composition or epigenetic 
state restricts passage of DNA polymerase.  
Whereas fragile sites do not seem to represent a 
problem in normally growing cells, the accelerated 
growth rate of cancer cells would specifically 
exacerbate the replication errors in fragile site loci and 
result in localized DSB (Crasta et al., 2012).  
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Figure 2. Epigenetic alterations in micronuclei suggest fundamental changes in chromatin physiology. CIN cells were labeled 
with antibodies against trimethylated Histone H3 (green), counterstained with the DNA marker DAPI (blue), and studied by fluorescence 
microscopy. Whereas the main nuclei showed low homogeneous labeling of chromatin, excluding the nucleoli, micronuclei revealed 
excessive levels of Histone trimethylation. 
 
Although fragile sites were initially attributed tostalled 
replication forks, later results have shown that the rate 
of origin firing, but not that of replication fork 
progression, is lowered in fragile sites (Letessier et al., 
2011). Since experimentally induced breaks at fragile 
sites depend on compounds that induce stalling of 
replication forks, these last results have opened a 
serious breach between laboratory and clinic. In the 
study that suggested interplay between S-CIN and 
DNA replication, DSB were detected without induction 
of stalled replication forks (Crasta et al., 2012). Instead, 
micronuclei formed after release from a block with 
microtubule depolymerizing agents accumulated DNA 
damage in the following cell cycle. However, whereas 
breaks in micronuclei were not obvious directly after 
cell division, they became evident in later cell cycle 
phases. Reduced levels of the MCM2 helicase subunit 
and delayed BrdU incorporation indicate that 
micronuclei formed in this way acquire DNA damage 
because DNA replication cannot keep up with normal 
cell cycle progression. Although the delayed replication 
and associated DSB in micronuclei are an interesting 
observation, they have not been attributed to a well-
defined molecular mechanism; the epigenetic 
composition of chromatin in micronuclei seems 
fundamentally different from that in the main nucleus 
(Figure 2), but the question what induces these 
differences remains to be answered. 
Micronucleus formation by spindle poison requires that 
a lagging chromosome remains at the metaphase plate 
long enough to be excluded from the main nucleus, 
indicating that merotelic spindle attachments are 
maintained during a considerable part of mitosis. The 
forces exerted by a prolonged merotelic attachment ca  
cause physical stretching of chromatin (Cimini et al.,
2001), to which the micronucleus might respond by 
epigenetic alterations, delayed replication, and DSB 
accumulation. Whereas the same effects are detectabl  
right after mitosis in SAC control mutants (Guerrero t 
al., 2010b), the treatment with microtubule-
destabilizing agents (Crasta et al., 2012) might relax the 
tension enough to reduce centromere stretching and 
delay a DNA damage response in the micronuclei. 
The proposed mechanisms for experimentally induced 
mitotic DSB appear to have different origins, but all are 
related to the mitotic spindle; whereas some models 
rely on genetic mutants that suffer from spindle defects 
(Guerrero et al., 2010b), other studies form monopolar 
spindles (Janssen et al., 2011) or require spindle 
assembly from a depolymerized state (Crasta et al., 
2012). The different outcomes, consequently, might 
also be spindle related; replication stress was found in 
micronuclei that arise through spindle defects (Guccini 
et al., 2012), cytokinesis related breakage was induce  
by suppressing kinases that control the SAC 
(Yamagishi et al., 2012), and merotelic kinetochore 
attachments are a consequence of defects in the control 
of mitotic microtubules (Cimini and Degrassi, 2005; 
Knowlton et al., 2006). A plausible explanation forthe 
variety of observations therefore is a common mitotic 
origin that results in a number of possible outcomes 
according to the parameters that are assayed. To 
determine which of the proposed mechanisms of DSB 
formation is relevant for carcinogenesis in humans, a 
survey of S-CIN in tumor samples is fundamental. 
The contribution of DSB repair to 
CIN 
Formation and repair of DSB are considered an 
important aspect of CIN irrespective of the model 
system used, because the translocations that 
characterize S-CIN cannot occur without breakage and 
fusion (Martínez and van Wely, 2011). Breakage 
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generates genomic fragments that might contain 
essential genes, the transmission of which is not 
guaranteed when separated from the rest of the 
chromosomes. Since DSB compromise cellular 
physiology, the natural tendency of cells is to repair 
any encountered breaks as soon as possible. The 
imperative to repair DSB is strong enough to put a 
brake on the normal cell cycle; not only do DSB slow 
interphase progression to prevent replication of 
damaged chromosomes, they also slow the metaphase 
to anaphase transition where the chance of segregating 
chromosome fragment into different daughter cells is a
real danger (Dotiwala et al., 2010). To repair DNA 
damage, mammalian cells bear a combination of 
pathways that perform overlapping and complementary 
roles (Bernstein et al., 2002). Whereas pathways 
specialized in the excision of damage at the basepair 
level important factors in MIN tumors (Roøyrvik et al., 
2007), homologous recombination (HRR) and 
particularly non-homologous end-joining (NHEJ) 
repair the DSB produced in S-CIN (Guerrero et al., 
2010b; Martínez and van Wely, 2011). Although a 
potential relation between HRR, NHEJ and S-CIN has 
been the subject of study for decades, no causal relation 
has been uncovered. Mutants in either HRR or NHEJ 
need more time to repair DSB when challenged (for 
example by irradiation), but the natural rate of DSB 
formation seems to be too low to cause significant 
accumulation of damage (Muller, 1950). In agreement 
with a low rate of spontaneous breaks, the frequency of 
sporadic - not induced- tumors is only moderately 
elevated in most repair mutants (Stiff et al., 2004). 
Thus, HRR and NHEJ have an important role in the 
processing of breaks but do not contribute significantly 
to their de novo formation. The situation is very 
different when the rate of DSB formation is raised; 
even relatively low doses of radiation or cytotoxic 
compounds can overwhelm existing repair 
mechanisms. Commonly, such treatments induce 
apoptosis in the target cells, but the small proportion of 
surviving cells might replicate in the presence of 
chromosomal translocations (Traut, 1963). 
Repair mechanisms likely contribute to the processing 
of chromosome fragments, because S-CIN is a direct 
consequence of breakage. Most CIN tumors have 
normal or even increased levels of DSB repair (Pucci et 
al., 2001; Hosoi et al., 2004; Cheng et al., 2010), 
probably to cope with the consequences of mitotic 
chromosome breaks. The importance of DSB repair is 
further emphasized by the lethal effects of repair 
deficiency in a CIN background (Guerrero et al., 
2010b); whereas mild repair defects or mild CIN are
tolerated individually, their combination causes 
synthetic lethality. Abrogation of NHEJ has 
particularly severe consequences for CIN cells 
(Guerrero et al., 2010b). This is understandable whn 
one takes the mitotic origin of CIN-related DSB into  
 
account; Not only is NHEJ the dominant repair 
pathway in mammalians, HRR is inactive right after 
mitosis due to the lack of substrate (Rothkamm et al., 
2003; Valerie and Povirk, 2003), and chromosome 
fragments in micronuclei are excluded from HRR due 
to the physical separation from a homologous 
counterpart. Notwithstanding the relatively mild effects 
of repair mutants if an additional source of DSB is 
absent, NHEJ has important tumor-suppressive 
properties because it can rapidly fuse chromosomal 
fragments and thus prevent loss or translocation of 
genome segments. 
Whereas HRR uses homologous substrates by 
obligation, NHEJ does not use sequence similarity. 
Although some subclasses of NHEJ use 
microhomology to compare the extremes of DNA 
fragments (Iliakis et al., 2004), this is not a 
prerequisite, and many fragments are joined without 
previous control. DSB repair by NHEJ occasionally 
involves the deletion of addition of a few bases at the 
site of fusion (Lukacsovich et al., 1994). These 
deletions and additions might eventually lead to 
frameshift mutations, but the potential to generate 
intragenic mutations of NHEJ appears insignificant 
compared to the base-pair alterations in MIN. 
However, the absence of control for homology also has 
important consequences for S-CIN, because this 
capacity to fuse unrelated DNA fragments is - together 
with the appearance of DSB - a critical step in the
generation of chromosomal translocations. 
Cells encounter an especially difficult situation when a 
merotelic attachment causes enough DNA damage in a 
centromere to separate the two arms of a single 
corresponding chromosome. When the two arms are 
segregated into different daughter cells - copy number 
analysis (Beroukhim et al., 2010; Bignell et al., 2010) 
shows that this situation occurs regularly -, the NHEJ 
repair machinery only encounters one half of its normal 
substrate after completion of mitosis. For the lack of a 
suitable counterpart, NHEJ may then fuse the solitary 
chromosome arm to a telomere, because this is the only 
structure that comes preloaded with part of the NHEJ 
protein complex and sufficiently resembles a break 
(Martínez and van Wely, 2011). In this case, NHEJ 
might promote carcinogenesis, since the resulting 
product is a chromosomal translocation - although the 
breakpoint do not map inside a chromosome arm - and 
possibly alters the copy number of an oncogene in the 
receiving cell. Thus, NHEJ can be a tumor-suppressiv  
as well as a tumor-promoting repair mechanism. 
Many of the surprising properties of NHEJ are never 
observed under experimental conditions, because 
irradiation or cytotoxic compounds artificially increase 
the number of DSB far above normal levels. These 
induced DSB however distribute in a random manner 
over the genome, instead of having a particular locati n 
related to natural cellular processes. Again, the choice  
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of model system for the study of DSB repair might bias 
results. Similarly, the one-sided view given by most 
experimental models might have biased conclusions 
regarding the role of telomeres in S-CIN (Martínez and 
van Wely, 2011). To validate the contribution of NHEJ 
and telomeres to cancer, the real life situation must be 
evaluated through the mapping of break- and fusion-
points in clinical samples. 
W-CIN and S-CIN in tumor samples 
and cell lines 
Whatever the experimental method used to induce 
breakage, the manipulation of a model system likely 
induces a bias with respect to the type and localization 
of DNA damage. Thus, although experimental models 
illustrate the possibility of a particular pathway to
induce DNA damage, they provide no information 
regarding the contribution of that pathway to CIN in 
real life. 
If an experimentally identified pathway participates in 
a clinical setting, at least some aspect of that pathw y 
must be found in tumor samples of sporadic cancer. 
Whereas it is common practice in the laboratory to 
disrupt protein function by gene targeting (Dobles et 
al., 2000; Guerrero et al., 2010b) or small molecul 
inhibitors (Janssen et al., 2011; Crasta et al., 2012), we 
must assume that the very first step of carcinogenesis 
occurs in normal cells. To bridge the gap between 
laboratory and clinic, a good indicator is to see by 
experiment if part of a molecular mechanism occurs 
spontaneously. Again, the phenomenon described in 
more detail, W-CIN, yields a number of useful clues. 
W-CIN is a common phenomenon even under 
physiological conditions (Compton, 2011). For 
example, aneuploidy is detected in approximately a 
third of all miscarriages (Hassold and Hunt, 2001), and 
nearly 80% of all human embryos contain aneuploid 
cells at the blastomere stage (Vanneste et al., 2009; 
Voet et al., 2011). W-CIN is also found regularly in 
some adult tissues, for example the brain (Rehen et al., 
2005). The ease by which W-CIN is detected in healty 
individuals shows that chromosome missegregation is a 
common origin of genetic defects, and probably occurs 
before other alterations in carcinogenesis. Nonethel ss, 
the frequency of aneuploidy nowhere is as high as in 
sporadic carcinomas (approximately 85%), indicating 
that CIN is a real requirement for cancer development. 
If one accepts that chromosome missegregation is a 
common phenomenon preceding other steps in 
tumorigenesis, a single mechanism leading to the 
combination of W-CIN and S-CIN - merotelic 
kinetochore attachments - must reveal its presence in 
tumor samples. Although merotelic attachments occur 
spontaneously non-transformed cultured cells (Cimini 
et al., 2001; Cimini et al., 2003), no direct methods 
have confirmed their presence in animals or humans. 
Lagging chromosomes are a key aspect of the three 
models for S-CIN presented above, and the clinical 
manifestation of lagging chromosomes - micronuclei –  
are an important clinical tool for cancer diagnosis 
(Kirsch-Volders et al., 1996; Kirsch-Volders et al., 
2002). These clinical cytogenetic techniques however 
provide suboptimal resolution to differentiate W-CIN 
and S-CIN, and therefore cannot support just one of the 
proposed mechanisms; genetic mapping of 
translocation breakpoints might help to make this 
distinction. 
Whereas merotelic kinetochore attachments have a 
direct connection to the centromere region of the 
chromosome (Guerrero et al., 2010a), no such 
preference has been described for actin ring 
chromosome capture in cytokinesis or delayed 
replication in micronuclei. Since translocations are a 
clinical manifestation of breakage, mapping of 
breakpoints to the centromere would thus specify 
merotelic attachments as the main cause. 
Unfortunately, centromeres largely contain repeat 
sequences not covered by the human genome project 
(Venter et al., 2001), precluding analyses with single-
base resolution such as massive parallel sequencing. 
The combined analysis of somatic copy number 
alterations (SCNA) and karyotyping nonetheless 
provides enough information needed to faithfully map 
centromeric breaks. The clinical manifestation of 
centromere fission, formation of individual 
chromosome arms, indeed is omnipresent in human 
cancers (Beroukhim et al., 2010; Bignell et al., 2010). 
Moreover, whereas the frequency of random breaks 
follows the statistical distribution predicted by the size 
of translocated chromosome fragments, whole-arm 
translocations occur at least ten times more often 
(Beroukhim et al., 2010). Other possible breakpoints, 
for example fragile sites brought about by replication 
defects, contribute only marginally to SCNA in the 
natural environment. The clinical data thus concur with 
a model for S-CIN that specifically includes 
centromere-localized breaks, and provide compelling 
evidence for the prevalence of merotelic attachments in 
human cancer. 
Clinical evidence for the role of 
NHEJ in S-CIN 
SCNA and karyotyping not only underline the 
importance of centromere fission, but also hint at he
mechanism by which NHEJ promotes carcinogenesis. 
Additional copies of chromosome arms limited by a 
centromeric break on one extreme and a telomere on 
the other rarely remain isolated fragments; the 
imperative to maintain an entire genome complement 
results in an almost obligatory fusion.  
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Figure 3. The combination of centromere fission and NHEJ lead to telomere capture in CIN tumors. If left uncorrected merotelic 
attachments (left) can exert enough force to physically stretch kinetochores and shear centromere DNA (arrow, middle) in mitosis. Upon 
exit from mitosis, HRR is inactive and NHEJ encounters only a "half substrate". Due to the preloading with NHEJ components, telomeres 
form an inefficient but viable ligation partner (right), to which isolated arms can be fused in tandem orientation. 
 
Depending on the moment of fusion - soon after 
mitosis or after DNA replication - and its subcellular 
location - in a micronucleus or together with other 
chromosomes -, and isolated chromosome arm 
commonly fuse with itself or with telomeres of healthy 
chromosomes (Martínez-A and van Wely, 2010; 
Martínez and van Wely, 2011). Whereas centromere to 
centromere fusions give rise to Robertsonian 
translocations and isochromosomes, the centromere to 
telomere fusions result in tandem ligation of the broken 
arm on the end of a healthy chromosome (Figure 3). In 
contrast to earlier proposals, in which telomere erosion 
was the driving force behind fusion in an antiparallel 
orientation, tandem fusion is caused by the ligation of a 
"half break" to a normal telomere. 
An overview of tumor karyotypes, revising nearly a 
hundred cases, has revealed that centromere-mediated 
fusions account for half of all translocations in sporadic 
carcinomas (Martínez and van Wely, 2011). These data
confirm that healthy telomeres offer protection against 
fusion with other standard chromosome ends, but can 
be a substrate of NHEJ when no suitable partner for a 
break is found. Even karyotypes attributed to actin ring 
constriction in cytokinesis show characteristic 
centromere to telomere fusions (Janssen et al., 2011), 
corroborating the role of merotelic attachments in 
spindle poison-induced DSB. In some karyotypes, a 
small proportion of isolated, but apparently stable 
chromosome arms can be found, that probably 
represent neoacrocentric chromosomes. These might 
have acquired a new telomere at the breakpoint through  
the alternative telomere elongation pathway (Gagos et 
al., 2008), which would suppress further recognitio by 
the NHEJ pathway. 
A final phenomenon linked to S-CIN is the 
amplification of proto-oncogenes. Multiple proto-
oncogenes, for example MYC and PIK3C, and some 
tumor-suppressor genes like INK4 show numerical 
changes without the acquisition of point mutations 
(Bignell et al., 2010), supporting the importance of S-
CIN as a separate oncogenic mechanism.  
In some tumors, dozens or more copies of these 
oncogenes are present, and other samples reveal 
homozygous deletion of tumor-suppressor genes. Such 
extremes cannot be reached by whole arm 
translocations alone, because this induces a severe gene 
dosage effect in the target cell. Instead, intra-arm 
breaks provide a selective mechanism that allows for 
the amplification or deletion of smaller chromosomal 
segments. Typically, proto-oncogenes such as MYC 
and PIK3C are located on arms that acquire a single 
additional copy without breakage in low-grade tumors 
but gain higher copy number when breakage allows for 
amplification of small segments (Bignell et al., 2010). 
Since centromere fission can generate isolated arms 
without or with a functional centromere, fusion of these 
can create a normal but extended or a dicentric 
chromosome, respectively (Martínez-A and van Wely, 
2010). Dicentric chromosomes are highly unstable, 
since the two centromeres might be segregated towards 
different spindle poles in a subsequent mitosis, causing 
renewed DSB and initiating breakage-fusion-bridge 
cycles.  
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Figure 4. Signatures of centromere fission and selection in tumor samples. The frequency distribution of breakpoints from a single 
chromosome is shown. Whereas whole arm translocations give rise to a sharp SCNA variation that coincides with the centromere (1), 
subsequent random breakage and positive selection of oncogene-containing segments results in a sloping SCNA distribution (2) that 
peaks around the oncogene (3). 
 
In contrast to the comparatively localized DSB 
generated by merotelic attachments, breaks in dicentr  
chromosomes can occur anywhere between the two 
centromeres.  
Even though centromere breaks account for a large 
proportion of SCNA, random breakage repaired by 
NHEJ is evident in tumor samples and cell lines 
(Beroukhim et al., 2010; Bignell et al., 2010). 
Karyotypes of advanced tumors generally reveal more 
W-CIN and S-CIN than those of low-grade cancer 
samples (Schröck et al., 1996; van Tilborg et al., 2002; 
Fabarius et al., 2003).  
Moreover, the complexity of translocations increases 
with tumor grade, indicating ongoing cycles of 
breakage and fusion in S-CIN. The typical sloping 
pattern of the breakpoint distribution, from a low 
frequency close to centromeres and telomeres to a high 
frequency surrounding the oncogenes (Figure 4), 
illustrates the combination of negative selection by 
bulk gene dosage and positive selection by the 
oncogene (Kost-Alimova et al., 2007). Probably, a 
combination of negative and positive selection 
determines cellular fitness during the gradual process 
of transformation in carcinogenesis. 
Gene dosage and cellular fitness 
Since the discovery of oncogenes, several decades after 
the first description of aneuploidy, a debate has taken 
place how copy number alterations can lead to cancer. 
Whereas the mutagenic effect of defects in DNA 
mismatch repair has contributed to the rapid acceptance 
of MIN as a potential cause of cancer, as similar 
relation between CIN and cancer has met with much 
more resistance. In part, the acceptance of oncogenes as 
a carcinogenic mechanism is based on historical 
arguments; the study of carcinomas required the 
induction and serial transfer of tumors from one animal 
to another of the same species until the development of 
cell culture. In the first half of the 20th century, transfer 
of virally induced tumors in birds and rodents proved to 
be a reliable way of tumor maintenance (van Epps, 
2005). A logical consequence of this historical heritage 
was the discovery of viral oncogenes and their human 
equivalents in the early days of molecular genetics 
(Pulciani et al., 1982). In contrast to birds and ro ents, 
however, the majority of human carcinomas seem to 
have no viral origin - some exceptions are hepatitis B 
and human papilloma virus - but instead arise 
spontaneously.  
Although the normal equivalents of viral oncogenes in 
the human genome, termed proto-oncogenes, 
frequently acquire mutations, this by no means is a 
universal requirement for carcinogenesis (Davies et al., 
2002). In MIN tumors, the mutagenic effect of defects 
in mismatch repair might produce a disposition for the
acquisition of mutations in proto-oncogenes, but the
same mutations in sporadic cancer might be acquired 
after the primary tumor has been established (Nowak et 
al., 2002). 
If oncogenic activation induces physiological 
alterations that surpass the limit of cellular adaptation, 
cellular senescence is induced (Sager, 1991). Cellsthus 
seem to have an intrinsic resistance against change s 
part of a general tumor-suppressive program. The 
resistance to change not only restricts the activation of 
individual gene products but also responds to a general 
gene dosage effect that results from the gains and 
losses of large chromosome fragments.  
Additional chromosomes in cultures cells are gradually 
lost, until the cells reverted to a mostly diploid state 
(Thompson and Compton, 2008).  
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W-CIN is a reversible condition, at least in vitro, and 
normal ploidy apparently is the condition of greatest 
cellular fitness.  
The burden of gene dosage is reflected in clinical 
conditions and in S-CIN, too, where the frequency a 
chromosome arm participates in translocations is 
inversely correlated with the number of genes on that
arm (Beroukhim et al., 2010).  
The observation that cancer cells preferentially lose 
small chromosomes (Duijf et al., 2013) shows that both 
gains and losses are limited by gene dosage. During 
some part of carcinogenesis, cancer cells must alter
their behavior to overcome the intrinsic resistance to 
gene dosage and tolerate the large-scale CIN seen in 
advanced tumors. Fusion to healthy chromosomes 
partly explains how entire chromosome arms are 
gained even though this compromises cellular fitness; 
the loss of the fused fragment that would return the cell 
to its optimal state is linked to the loss of the acceptor 
chromosome by the fusion. Thus, the return to an 
optimal diploid state for the donor arm can only be 
achieved by a haploid state of the acceptor 
chromosome and results in an even more severe gene 
dosage penalty. For this reason, clinical samples in 
which additional arms fused in tandem to other 
chromosomes are the only karyotype alteration are 
quite common (Martínez and van Wely, 2011). 
Some studies have suggested that tumors arise through 
a tetraploid state followed by gradual loss of 
chromosomes (Gisselsson, 2011). Such a diploid state 
might give rise to relatively mild gene dosage effects 
because all genes are amplified proportionally. Once 
polyploid cells have lost a dozen or so chromosomes, 
however, gene expression will suffer from an extreme 
disequilibrium unlikely to be overcome.  
The recurrent translocation of the same chromosome 
arm, without additional genetic defects, in low-grade 
tumors contradicts the role of a tetraploid intermediate, 
but instead indicates that a gradual acquisition of 
additional genetic material is the normal pathway in 
CIN. Polyploidy usually is the result of an aborted 
duplication, and is accompanied by amplification of the 
centrosomes that form the spindle poles in mitosis 
(Duensing and Duensing, 2010). Due to the presence of 
multiple spindle poles, chromosome segregation in 
polyploid cells nearly always leads to a mitotic 
catastrophe and rapid cell death (Vitale et al., 2011). 
A survey of genes that induce tolerance for aneuploidy 
identified pathways that promote protein turnover, 
especially the ubiquitin proteasome system (Torres et 
al., 2010). The potential of similar pathways to be 
treated with anticancer drugs are being studied actively 
(Chen and Dou, 2010).  
The most important effect of gene dosage discovery 
until now is the production of improperly folded 
protein intermediates, which induces a cellular stress 
response that activates the pro-apoptotic p53 pathway 
(Herr and Debatin, 2001; Zhang et al., 2006). Nearly  
century after the first description of aneuploidy 
(Boveri, 1914), the unfolded protein response is the
first potential mechanism to explain malignization f 
CIN tumors; prolonged low level activation of a pro-
apoptotic pathway in response to gene dosage 
potentially leads to the selection of mutants that 
suppress apoptosis through additional - numerical, 
structural, or sequence-dependent - mutations. Similar 
spill-over effects of the unfolded protein response, 
possibly involving the ubiquitination (Torres et al., 
2010) essential for controlled protein degradation in 
mitosis, might be an important determinant in the 
development of ongoing chromosomal instability. 
Finally, spill-over effects might explain the shift in 
epigenetic modifications such as promoter methylation, 
since the additional genome segments compete for 
transcription factors that could become a limiting factor 
in the nucleus. Thus, the general interwoven nature of 
signaling pathways makes mammalian cells susceptibl 
to imbalance, where CIN can be both driving force and
consequence. 
Concluding remarks 
Considering the contributions of centromere fission and 
NHEJ - phenomena that act in an indiscriminate 
manner, but on single chromosomes -, it is easier to 
grasp the near random nature of cancer development.  
Off course, one has to consider the modulating effects 
of individual genes on the global imbalance brought 
about by gene dosage. Not only the shear number of 
genes on a chromosome arm but also their expression 
level - think of tumor-specific markers - and particular 
function in cell survival - the "general" oncogenes and 
suppressor genes - play a role. In the end, a neo-
Darwinistic model comprising randomized CIN and 
modulation by specific survival factors seems to give a 
reasonable description of carcinogenesis. 
A question that remains to be answered is how genetic 
alterations that apparently reduce cellular fitness can 
lead to transformation and carcinogenesis.  
We are accustomed to relate cancer to oncogene 
activation, and only see the fast-growing cells that 
appear at the end of the carcinogenic process, but these 
might be the result and not the cause of transformation. 
Although the final stages of carcinogenesis indeed are 
associated with a cell population that proliferates 
rapidly, has accumulated a variety of genetic defects, 
and acquired a certain degree a malignancy, the same 
does not necessarily hold true for the initial stages. The 
near universal presence of CIN, albeit associated with 
gene dosage, shows that some cells continue to 
proliferate in the body when their fitness is 
compromised.  
This conclusion has been made before in a different 
context; radiation promotes formation of leukemia even 
though it has the potential to induce apoptosis. The 
prevalence of small chromosomes alterations in low-
grade tumors - comparable to a low radiation dose - 
corroborates the classical stepwise model of 
carcinogenesis, in which gradual cycles of stimuli and 
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adaptations lead to drastic alterations after multiple 
iterations (Vogelstein et al., 1988). 
Considering the reduced fitness associated with W-CIN 
and S-CIN, the cells where the initial steps of 
carcinogenesis occur must somehow tolerate gene 
dosage. The discovery of cancer stem cells might 
explain this tolerance towards gene dosage in the near
future, since stem cells might unite the exact prope ties 
to form cancer precursors (van Wely and Martínez, 
2012). Firstly, apoptotic control in stem cells is less 
than strict, since tight control might eliminate the self-
renewing population and endanger long-term tissue 
maintenance. Next, the predisposition to differentiate 
might prepare stem cells for a rapid change in gene 
expression, accompanied by tolerance for gene dosage. 
Finally, the sustained replication of stem cells means 
they are at risk for chromosome segregation; since each 
mitosis has a small risk of erroneous chromosome 
segregation, many division result in a large cumulative 
risk. To maintain the balance between tissue renewal 
and genome stability requires making the right decision 
in each cell cycle during the entire life of the organism; 
in the end, one could consider that cancer is the effect 
of stem cell indecisiveness. The design of experiments 
that faithfully model cellular decision-making will be a 
challenge for the understanding of carcinogenesis in the 
next years. 
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